Sleep TechnologyRespiratorySurgeryEar Nose & Throat (ENT)Biomedical EngineeringHealth CareManufacturingMedical Device
Description
Fisher & Paykel Healthcare Corporation Limited engages in the design, manufacture, and marketing of products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. Its products are sold in approximately 120…
Analysis
Beloved champion
Fisher & Paykel Healthcare Corporation Limited sits in the top corner of our grid: excellent business, premium price; every investor already knows the story. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is expensive. The owner-earnings multiple stands at 54.3×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 20% a year, against analyst forecasts of 19%. The price, in other words, assumes less than the experts do.
Growth is solid; the safety picture is sturdy. The company scores 16/20 on our value-creation score: strong value creator.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202321
68
2023202420252026
All-time high
88
Jan 2026
All-time low
21
Jan 2023
Average rank
75
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
7
3
7
13
Price/Earnings
17
11
14
19
Price/Book
4
7
7
9
Dividend Yield
67
32
45
55
Value (overall)
14
10
12
24
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.